— Know what they know.
Not Investment Advice

IMTX NASDAQ

Immatics N.V.
1W: -3.3% 1M: -14.6% 3M: -19.2% YTD: -30.5% 1Y: -28.7% 3Y: -16.7% 5Y: -45.2%
$7.26
+0.11 (+1.54%)
 
Weekly Expected Move ±8.8%
$6 $7 $7 $8 $9
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 34 · $1.1B mcap · 128M float · 0.510% daily turnover · Short 33% of daily vol
Credit Risk of going bust: lower than 82% of companies Debt: 1.5% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.00 (down 99.9%), Immatics N.V. would be worth roughly what it owes.
Total debt $16.2M against a stock market value of $1.09B.
Distance to default 10.11 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $3.0M (short-term plus half of long-term), stock volatility 57.4%; Altman Z'' 0.97. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

📊 Key Metrics

TTM
$42M
Revenue
-68.0% YoY
$-207M
Net Income
-179.5% YoY
$-210M
Free Cash Flow
-20.2% YoY
100.0%
Gross Margin
-735.0%
Op. Margin
-683.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-47.8%
ROA-39.2%
ROIC-858.3%

Valuation

P/E-4.1
P/B2.2
EV/EBITDA0.0

Leverage

Debt/Equity0.04
Current Ratio7.54
Interest Cov.-237.2x

Quality Scores

Piotroski F2/9
Altman Z—
Beneish M-0.99

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms